Samira Rostom
Overview
Explore the profile of Samira Rostom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zemrani S, Amine B, ElBinoune I, Rostom S, Bahiri R
Mediterr J Rheumatol
. 2025 Feb;
35(Suppl 3):549-556.
PMID: 39974589
Objectives: High biologic requirement in inflammatory rheumatic diseases (IRD) may indicate a difficult to treat (D2T) condition. In axial spondyloarthritis (axSpA), a consensual definition for this concept is still lacking....
2.
Zemrani S, Amine B, El Binoune I, Rostom S, Tahiri L, Allali F, et al.
Cureus
. 2024 Oct;
16(9):e70365.
PMID: 39469413
Background and objective Secukinumab (SECU) is a biologic disease-modifying antirheumatic drug (bDMARD) that has demonstrated effectiveness against axial spondyloarthritis (ax-SpA). However, in clinical practice, secukinumab is most commonly used as...
3.
Zemrani S, Amine B, ElBinoune I, Rostom S, Bahiri R
Joint Bone Spine
. 2024 Sep;
92(1):105779.
PMID: 39332665
No abstract available.
4.
El-Kasmi H, Amine B, Kabbaj A, Rostom S, El Binoune I, El Hilali S, et al.
Cureus
. 2024 Aug;
16(7):e64011.
PMID: 39109111
Introduction Fibromyalgia (FM) is characterized by widespread pain and fatigue, accompanied by symptoms such as decreased concentration, autonomic dysfunction, and abdominal pain. It can be either primary or secondary, notably...
5.
Oulkadi L, Rostom S, Hmamouchi I, El Binoune I, Amine B, Abouqal R, et al.
Mediterr J Rheumatol
. 2022 Sep;
33(2):224-231.
PMID: 36128204
Objectives: The aim of this study was to determine the therapeutic maintenance level of methotrexate for rheumatoid arthritis patients enrolled in the Moroccan biotherapy registry and to identify predictive factors...
6.
Oulkadi L, Rostom S, Hmamouchi I, El Hassani Sbai S, El Binoune I, Amine B, et al.
Rheumatol Int
. 2021 Jun;
41(9):1625-1631.
PMID: 34173843
Before the initiation of biotherapy in the treatment of rheumatic diseases, it is highly recommended for the patients to be screened for latent tuberculosis infection (LTBI). The objective of this...
7.
Eddaoudi M, Rostom S, Hmamouchi I, El Binoune I, Amine B, Abouqal R, et al.
Pan Afr Med J
. 2021 May;
38:183.
PMID: 33995789
Introduction: the aim of our study is to determine, from data of the Moroccan register of biotherapies, the factors influencing the choice of the first prescribed biological treatment. Methods: cross-sectional...
8.
Bentaleb I, Abdelghani K, Rostom S, Amine B, Laatar A, Bahiri R
Curr Clin Microbiol Rep
. 2020 Oct;
7(4):124-132.
PMID: 33014690
Purpose Of Review: The aim of this paper is to provide an overview about reactive arthritis, with an update regarding pathophysiology and therapeutic approach of the disease, outlining the clinical...
9.
Bencherifa S, Amine B, El Binoune I, Rostom S, Bahiri R
BMC Rheumatol
. 2020 Feb;
4:6.
PMID: 32055765
Background: Peripheral ulcerative keratitis (PUK) is a severe inflammatory ocular disease that can affect patients with a long history of rheumatoid arthritis (RA). The use of biotherapy has revolutionized the...
10.
Eddaoudi M, Rostom S, Amine B, Bahiri R
Pan Afr Med J
. 2020 Jan;
34:102.
PMID: 31934245
Rheumatoid arthritis rarely involves the cricoarytenoid joint, symptoms of varying severity ranging from foreign body sensation, fullness or tension in the throat, hoarseness, odynophagia, speech or cough pain to stridor...